Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

Medical Devices Multi

The medical device industry is highly segmented, and with that segmentation comes specific circumstances and trends. They remain united, however, by two overarching and closely linked waves of change. Firstly, payers are increasingly making the switch from service-based to value-based healthcare. Secondly, rapid adoption of digital technologies is transforming the way in which healthcare is delivered everywhere.

Changes in the reimbursement method inevitably lead to changes in the business model; many companies that had previously addressed specific points in the care pathway are now seeking to provide services across the entire continuum of care.

While rapid digitisation has completely revolutionised other markets, the regulatory regimes overseeing medical devices have slowed digital transformations in this industry. Still, the potential for change is sizeable. Medical device companies must consider how the reducing costs of sensing/processing/communication combined with customers and companies’ increasing familiarity with digital services will improve their offer.

For certain care pathways, moving to lower cost environments will be attractive to both payers and to patients, the latter of whom may prefer to receive their treatment at home. This presents new design challenges in order to ensure that complex medical equipment can function effectively in these contexts.

TTP works with its clients to bring new medical devices to the changing marketplace. Projects can include some or all of the process, from identifying new opportunities, to concept generation, design and manufacturing support.

Explore More industries

Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.


Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.


Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals in real time.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

Healthcare consumers are no longer willing to accept a poor user experience, and the consumer world has set their expectations sky-high. We design products and health experiences encompassing both physical and digital products for the healthcare consumers of tomorrow.

Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.


Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Cell and Gene Therapy

Cell and Gene Therapies can cure the incurable. With more than a decade of experience, TTP works in partnership with companies to solve the challenges of these complex therapies. Together we will improve patient access and save lives.


Neurotechnology promises to revolutionise the treatment of a wide range of diseases. Improving outcomes for patients depends on bringing together an understanding of the pathology with the medical device hardware needed to physically interface with the nervous system.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.